Tahlia Scheinberg

9PUBLICATIONS
18CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCancer geneticsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 07, 2025
Immunotherapy in metastatic prostate cancer.

Liam Dwyer, Claudia Leslie, Rhiannon Mellor

|Nov 21, 2023
An Australian mainstream genetic testing program: Clinicians views about current and future practices.

Alison Luk Young, Emilia Ip, Tahlia Scheinberg

|May 05, 2023
PCPro: a clinically accessible, circulating lipid biomarker signature for poor-prognosis metastatic prostate cancer.

Tahlia Scheinberg, Hui-Ming Lin, Michael Fitzpatrick

|Feb 06, 2023
Targeting lipid metabolism in metastatic prostate cancer.

Tahlia Scheinberg, Blossom Mak, Lisa Butler

Pageof 2